Obesity, Metabolic Syndrome, and ‘Difficult-to-Treat’ Psoriatic Arthritis Is Inflammation Only Half the Story Review Abstract Psoriatic arthritis (PsA) is a chronic, immune mediated inflammatory musculoskeletal disease that affects a substantial proportion of individuals with psoriasis. Characterized by peripheral arthritis, enthesitis, dactylitis, axial involvement, and progressive joint damage, PsA is associated
Tag: cardiovascular risk
Contemporary Lipid Management in Family Practice: Risk Stratification, Coronary Artery Calcium, and Shared Decision-Making for Statin Therapy
Contemporary Lipid Management in Family Practice: Risk Stratification, Coronary Artery Calcium, and Shared Decision-Making for Statin Therapy Review Abstract Purpose: This paper examines current approaches to lipid management in family practice, focusing on risk stratification methods, the role of coronary artery calcium scoring, and implementation of
The Rise of Precision Lipidology: Beyond LDL-C to ApoB, Lp(a), and Atherogenic Particle Burden
The Rise of Precision Lipidology: Beyond LDL-C to ApoB, Lp(a), and Atherogenic Particle Burden Review Abstract Lipidology is undergoing a clinically important transition from traditional cholesterol-centered assessment toward a more precise evaluation of atherogenic lipoprotein burden. Low-density lipoprotein cholesterol (LDL-C) remains a validated therapeutic target
Microplastics in Coffee Pods: Current Evidence and Potential Health Implications
Microplastics in Coffee Pods: Current Evidence and Potential Health Implications Key Takeaways Research reveals alarming levels of microplastic contamination in single-use coffee pods, with significant health implications for daily coffee drinkers and actionable solutions available. • A single plastic coffee pod can release over
Why GLP-1 Receptor Agonists Are Becoming Essential Cardiovascular Drugs
Why GLP-1 Receptor Agonists Are Becoming Essential Cardiovascular Drugs Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a transformative class of medications in the management of type 2 diabetes, demonstrating an approximate 14 percent reduction in major adverse cardiovascular events. Initially developed
The Surprising Link Between Psoriasis and Heart Disease: What Patients Need to Know
The Surprising Link Between Psoriasis and Heart Disease: What Patients Need to Know Introduction Psoriasis and cardiovascular disease are closely connected in ways that extend well beyond coincidental comorbidity. Psoriasis affects approximately 2 to 3 percent of the U.S. population, and individuals with this chronic inflammatory
Reevaluating the Annual ECG: Screening Tool or Waste of Resources?
The Hidden Burden of Subclinical Hypothyroidism: When to Treat and When to Watch
The Hidden Burden of Subclinical Hypothyroidism: When to Treat and When to Watch Check back later for a possible video summary. Videos are created for most articles. Abstract Background:Subclinical hypothyroidism (SCH) is defined by elevated serum thyroid-stimulating hormone (TSH) levels alongside normal free thyroxine
New Blood Pressure Guidelines: Why 130/80 mm Hg Sparks Fresh Debate in 2025
Polypills for Cardiovascular Disease Prevention: Smart Innovation or Oversimplification?
Polypills for Cardiovascular Disease Prevention: Smart Innovation or Oversimplification? Check back later for a possible video summary. Videos are created for most articles. Abstract The polypill, a fixed-dose combination of multiple cardiovascular medications in a single pill, represents a major shift in
